Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.
Domain
pyxisoncology.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$50.0M
Founded
2018
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Pyxis Oncology use?+
Pyxis Oncology uses 17 technologies including Astra, Elementor, Font Awesome.
What industry is Pyxis Oncology in?+
Pyxis Oncology operates in the Biotechnology industry.
Where is Pyxis Oncology based?+
Pyxis Oncology is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026